ID22916A - Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin - Google Patents

Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin

Info

Publication number
ID22916A
ID22916A IDW991445A ID991445A ID22916A ID 22916 A ID22916 A ID 22916A ID W991445 A IDW991445 A ID W991445A ID 991445 A ID991445 A ID 991445A ID 22916 A ID22916 A ID 22916A
Authority
ID
Indonesia
Prior art keywords
ergolin
decreases
receptor antagonists
somatostatin receptor
somatostatin
Prior art date
Application number
IDW991445A
Other languages
English (en)
Indonesian (id)
Inventor
Paul Pfaeffli
Peter Neumann
Robert Swoboda
Peter Stutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID22916A publication Critical patent/ID22916A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C07D457/08—Lysergic acid amides in which the amide nitrogen is a member of a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW991445A 1997-05-29 1998-05-27 Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin ID22916A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711043.1A GB9711043D0 (en) 1997-05-29 1997-05-29 Organic compounds

Publications (1)

Publication Number Publication Date
ID22916A true ID22916A (id) 1999-12-16

Family

ID=10813201

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991445A ID22916A (id) 1997-05-29 1998-05-27 Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin

Country Status (24)

Country Link
US (1) US6221870B1 (cs)
EP (1) EP0986558A2 (cs)
JP (1) JP2001527580A (cs)
KR (1) KR20010013103A (cs)
CN (1) CN1259946A (cs)
AR (1) AR012870A1 (cs)
AU (1) AU727841B2 (cs)
BR (1) BR9809491A (cs)
CA (1) CA2288810A1 (cs)
CO (1) CO4950561A1 (cs)
CZ (1) CZ289466B6 (cs)
GB (1) GB9711043D0 (cs)
HU (1) HUP0002311A3 (cs)
ID (1) ID22916A (cs)
IL (1) IL132571A0 (cs)
NO (1) NO995482L (cs)
NZ (1) NZ500386A (cs)
PE (1) PE74899A1 (cs)
PL (1) PL336502A1 (cs)
RU (1) RU2191776C2 (cs)
SK (1) SK160899A3 (cs)
TR (1) TR199902848T2 (cs)
WO (1) WO1998054183A2 (cs)
ZA (1) ZA984560B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10341317B4 (de) * 2003-09-03 2008-10-23 Axxonis Pharma Ag Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
MXPA03011321A (es) * 2001-06-08 2004-12-06 Conseils De Rech S Et D Aplica Analogos quimericos de somatostatina-dopamina.
MXPA05010868A (es) * 2003-04-11 2005-11-25 Conseils De Rech S Et D Aplica Analogos quimericos de somatostatina-dopamina.
FI20031454A0 (fi) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
KR101000923B1 (ko) * 2004-01-08 2010-12-13 삼성전자주식회사 원격 제어기의 매크로 설정 장치 및 방법
EP1885693A4 (en) * 2005-05-18 2010-09-15 Siegfried Wurster HIGH SELECTIVITY PEPTIDOMIMETICS FOR SOMATOSTATIN RECEPTOR 1 AND / OR 4 SUBTYPES
JP2007067096A (ja) * 2005-08-30 2007-03-15 Fujitsu Ltd 半導体装置
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
AU2012272780A1 (en) 2011-06-23 2014-01-09 Map Pharmaceuticals, Inc. Novel fluoroergoline analogs
CA2859173A1 (en) 2011-12-19 2013-06-27 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
WO2013095708A1 (en) 2011-12-21 2013-06-27 Map Pharmaceuticals, Inc. Novel neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
HK1213486A1 (zh) 2012-11-01 2016-07-08 Ipsen Pharma S.A.S. 促生长素抑制素类似物及其二聚体
US9657020B2 (en) 2015-01-20 2017-05-23 Xoc Pharmaceuticals, Inc. Ergoline compounds and uses thereof
US9676776B2 (en) 2015-01-20 2017-06-13 Xoc Pharmaceuticals, Inc. Isoergoline compounds and uses thereof
WO2018223065A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
JP7099717B2 (ja) 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695682U (de) * 1955-01-13 1955-03-31 Otto Berning & Co Verstellbares kragenstaebchen.
US3592816A (en) 1966-02-08 1971-07-13 Sandoz Ltd N-substituted piperazides of lysergic acid
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
GB1188197A (en) 1967-10-11 1970-04-15 Sandoz Ltd Lysergic Acid Derivatives
NL6818658A (cs) * 1968-01-18 1969-07-22
GB1580448A (en) * 1976-12-06 1980-12-03 Farmaceutici Italia 8 -acetyl-6-methyl-ergoline i derivatives
GB8501078D0 (en) * 1985-01-16 1985-02-20 Erba Farmitalia Piperazin-1-yl-ergo-line derivatives
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives

Also Published As

Publication number Publication date
EP0986558A2 (en) 2000-03-22
GB9711043D0 (en) 1997-07-23
AU727841B2 (en) 2001-01-04
CO4950561A1 (es) 2000-09-01
HUP0002311A3 (en) 2002-08-28
RU2191776C2 (ru) 2002-10-27
SK160899A3 (en) 2000-07-11
HUP0002311A2 (hu) 2000-12-28
US6221870B1 (en) 2001-04-24
TR199902848T2 (xx) 2000-02-21
JP2001527580A (ja) 2001-12-25
PL336502A1 (en) 2000-07-03
PE74899A1 (es) 1999-09-14
CN1259946A (zh) 2000-07-12
AR012870A1 (es) 2000-11-22
WO1998054183A3 (en) 1999-03-04
ZA984560B (en) 1998-11-30
BR9809491A (pt) 2000-10-17
NZ500386A (en) 2002-05-31
NO995482D0 (no) 1999-11-09
AU8210898A (en) 1998-12-30
IL132571A0 (en) 2001-03-19
CZ424599A3 (cs) 2000-03-15
KR20010013103A (ko) 2001-02-26
NO995482L (no) 1999-11-09
WO1998054183A2 (en) 1998-12-03
CZ289466B6 (cs) 2002-01-16
CA2288810A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
ID22916A (id) Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID19623A (id) Antagonis reseptor vitronektin
ID26099A (id) Turunan amida dan antagonis nosiseptin
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
ID26248A (id) Turunan asiguanidina baru sebagai inhibitor penyerapan tulang dan sebagai antagonis reseptor vitronektin
DE69833073D1 (de) CCR-3-Rezeptor-Antagonisten
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
EP0986385A4 (en) GONADORELIN ANTAGONISTS
HUP0103796A3 (en) Neuropeptide y5 receptor antagonists and medicaments containing them
ID16742A (id) Antagonis reseptor endotelin
NO993350D0 (no) Vitronectin-reseptor-antagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
ID27544A (id) Agonis dan antagonis muskarinat
ID26223A (id) Antagonis reseptor vitronektin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
GB9820014D0 (en) Receptor antagonists and uses thereof
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID28811A (id) Antagonis reseptor vitronektin
ID24306A (id) Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori
PT964867E (pt) Antagonistas da taquicinima
ID24346A (id) Turunan asam karboksilat betha -amino dan betha -azido baru, pembuatan dan penggunaannya sebagai antagonis reseptor andotelin